BioSpace News Archive

Drug Development

Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

Ambrx Inc. announced that Bristol-Myers Squibb Company has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of long-acting Relaxin for the potential treatment of heart failure.

July 16, 2019
·
2 min read
Business

Glooko Appoints Stephen Lien as New Chief Financial Officer

Accomplished finance and operations leader brings deep experience in SaaS and healthcare technology to continue acceleration of diabetes data management leader’s growth

July 16, 2019
·
3 min read
Business

Pall Corporation Chosen as Single-Source Supplier by Servier for Purpose Built End-to-End Biomanufacturing Facility in Gidy, France

Pall Corporation, a global leader in filtration, separation and purification, has been chosen by Servier, an independent international pharmaceutical company, as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.

July 16, 2019
·
3 min read
Job Trends

Central Logic Unveils Solution Update to Further Speed Time to Care

Significant technology milestones streamline transportation requests and call recording attachments; both help patients receive the right level of care, right location, without delay

July 16, 2019
·
2 min read
Genetown

InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord

InVivo Therapeutics Holdings Corp. announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data.

July 16, 2019
·
2 min read
Drug Development

Axial Biotherapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder

AB-2004 has demonstrated the ability to repair leaky gut and improve repetitive behavior, anxiety and Autism Spectrum Disorder (ASD)-related sensorimotor gating deficits by removing key microbial metabolites.

July 16, 2019
·
2 min read
Grifols presents additional encouraging Alzheimer’s trial results at AAIC

New data shows positive impact of AMBAR treatment on efficacy endpoints combining cognition and function in all patients treated The results are in line with the ones presented in CTAD in Barcelona and AD/PD in Lisbon

July 16, 2019
·
8 min read
Sobi Invites Entries to First Sobi Scientific Innovation Awards

Sobi™ has established the Sobi Scientific Innovation Awards, with a focus on the future of haemophilia care, to recognise innovation and scientific excellence in haemophilia research.

July 16, 2019
·
3 min read
Biotech Bay

AdhereHealth Selects Paxata to Accelerate Medication Adherence Solution Implementations Through Adaptive Data Preparation Technologies

Leading healthcare technology company implements machine learning-based self-service data platform to rapidly transform raw client data into reliable information to deliver better outcomes

July 16, 2019
·
4 min read
Business

Johnson & Johnson Reports 2019 Second-Quarter Results

Sales of $20.6 billion reflecting a decline of 1.3%, operational growth of 1.6%* and adjusted operational growth of 3.7%*

July 16, 2019
·
11 min read